All the news Showing 10 of 87 articles from: NAFLDGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Liver fibrosis assessment in routine care for diabetic patients could uncover a hidden population of people living with advanced liver disease EASL / 28 August 2020 Two novel treatments show promise in improving biomarkers of NASH pathology EASL / 28 August 2020 Fatty Liver Disease Tied to Metabolic Health Conditions in People With HIV Poz / 24 August 2020 Diabetes More Than Doubles Risk of Advanced Liver Disease HepMag / 27 July 2020 Women Suffer Less NAFLD but More Advanced Fibrosis Medscape (requires free registration) / 27 July 2020 NASH is fastest-growing reason for a liver transplant in United States Keith Alcorn / 22 June 2020 Non-alcoholic steatohepatitis (NASH), the severe form of non-alcoholic fatty liver disease (NAFLD), is now the most common reason for a liver transplant in women, older patients and people receiving Medicare insurance in the ... Global Liver Institute’s International NASH Day Convenes 80 Partner Organizations and 30 Speakers to Declare Urgency of Combatting Parallel Epidemics of Liver Disease and COVID-19 Global LIver Institute / 15 June 2020 Non-alcoholic fatty liver disease does not raise the risk of COVID-19, gene study shows Keith Alcorn / 26 May 2020 People with a genetic profile that strongly predicts non-alcoholic or metabolic-associated fatty liver disease were not at higher risk of being hospitalised with COVID-19 in the United Kingdom, an analysis of the ... Non-alcoholic fatty liver disease affects a quarter of lean people living with HIV Michael Carter / 13 May 2020 A quarter of people living with HIV with normal body weight have non-alcoholic-fatty liver disease (NAFLD), Italian and Canadian investigators report in Clinical Infectious Diseases. Risk factors were older age, ... Fatty liver disease may increase risk of severe COVID-19 disease Keith Alcorn / 27 April 2020 A preliminary analysis of people admitted to hospital in China with COVID-19 symptoms shows that people with non-alcoholic fatty liver disease (NAFLD) were six times more likely to progress to severe COVID-19 ... ← Prev12345...9Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD NASH Experimental treatments for NASH/NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive